COVID-19 Vaccine Efficacy Higher With Three-Month Interval Between Doses
For ChAdOx1 nCoV-19 Oxford vaccine, three-month interval results in higher efficacy than six-week interval
Diagnosis & Disease Information
AstraZeneca COVID-19 Vaccine Approved by the WHO
This is the second such approval from the WHO, which gave the Pfizer vaccine the green light in December
- Loading...
Loading...
Next post in News
Loading... 
Loading...